destinationCME

05/27/2026

Anesthesia Camp Grand Cayman flashback. With my co-resident at the University of Virginia, Dr Guy Weinberg, inventor of lipid rescue.💉⚕️ We get the best faculty! 👨🏽‍🏫
Anesthesia Camp Grand Cayman at The Ritz-Carlton Resort. Up to 28hr CME. 😎🌞🩴👙🏖️🤿🇰🇾🏌🏽‍♀️🎾
destinationCME.com
🗓️1/27/2027 - 1/30/2027

05/27/2026

British🇬🇧 /Irish🇮🇪 periop HTN guidelines. You agree with their cancellation criteria???
> Measurement and management of adult blood pressure in the peri-operative period: updated guidelines from the Association of Anaesthetists and the British and Irish Hypertension Society
> Authors: McCormack T, Wickham A, McDonagh STJ, Wiles MD, Faconti L, Brooks R, Anderson SG, Hartle A.
> Journal: Anaesthesia
Publication Date: January 14, 2026 (Online Ahead of Print / March 2026 Issue)
Volume/Issue: Volume 81, Issue 3, Pages 402–414
DOI: 10.1111/anae.70082
PubMed ID: PMID: 41532177

05/26/2026

When I was a resident, we used esophageal stethoscopes to listen to heart tones and took q5-minute manual blood pressures. Pulse oximeters came out towards the end of my residency. Capometry followed.
New technology came in and we lost the ability to discern muffled heart tones with decreased cardiac output. Was that a bad thing?
This is always a concern with new technology. Watch this space!
> thelancet.com/journals/lancet/article/PIIS0140-6736(25)02075-6/abstract
> x.com/i/status/2059291536404480063

05/26/2026

Perioperative Vasopressor Management in Noncardiac Surgical Patients
https://pubmed.ncbi.nlm.nih.gov/41384618/
"Physiologic concert of the adrenergic, vasopressinergic, and renin–angiotensin systems in blood pressure homeostasis, and select mechanisms of pharmacologic vasopressors."
Review 🗞️ PDF: https://bit.ly/periop-vasopressors

05/24/2026

05/24/2026

Pendulum swung too far for cannabis? x.com/i/status/2046289244076073321
NYT Editorial Board: It’s Time for America to Admit That It Has a Ma*****na Problem. https://nyti.ms/3PIao2m (unlocked)

"The biggest concern is excessive use. At least one in 10 people who use ma*****na develops an addiction, a similar share as with alcohol. Even some who do not develop an addiction can still use it too much. People who are frequently stoned can struggle to hold a job or take care of their families. “As ma*****na legalization has accelerated across the country, doctors are contending with the effects of an explosion in the use of the drug and its intensity,” a New York Times investigation concluded in 2024. “The accumulating harm is broader and more severe than previously reported.”"

05/24/2026

"Many physicians in the crowd said they worried that Mr. Kennedy’s statements would prompt people to refuse medications, or to quit them and relapse. The plenary session erupted in applause when Dr. Marketa Wills, the organization’s chief executive, declared, “We will never support governmental interference in the practice of medicine.”

“We are standing tall for evidence-based care,” she continued. “We are standing tall against stigma, oversimplification, and anything that would move patients further away from the care that they need.”

https://www.nytimes.com/2026/05/24/science/rfk-jr-antidepressants-ssri-psychiatry.html

05/23/2026

Anesthesia Camp Grand Cayman at The Ritz-Carlton Resort. Up to 28 hr CME/CE. 😎🌞🩴👙🏖️🤿🇰🇾🏌🏽‍♀️🎾
destinationCME.com
🗓️1/27/2027 - 1/30/2027

05/22/2026

"ASA continues to agree with the position of the American Medical Association on physician involvement in capital punishment. ASA strongly discourages participation by anesthesiologists in executions." https://www.asahq.org/standards-and-practice-parameters/statement-on-physician-nonparticipation-in-legally-authorized-executions
NYT article: https://www.nytimes.com/2026/05/21/us/tennessee-execution.html

05/22/2026

Who is ready for some world-class continuing medical education with a view? 🌊🌴
One of the most highly anticipated topics we will be tackling at Anesthesia Camp Grand Cayman 2027 is the rapid evolution of Enhanced Recovery After Surgery (ERAS) pathways. A perfect example of why we must constantly review our practices is the recent GAP Study published in Anesthesiology.
Many of us trained using gabapentin as an essential opioid-sparing adjunct. However, this large 2025 randomized controlled trial showed that adding gabapentin to a multimodal regimen for major surgeries (cardiac, thoracic, abdominal) failed to reduce hospital length of stay or significant opioid use, while surprisingly increasing the incidence of reported pain at the 4-month mark.
It’s a great reminder that our perioperative protocols must be guided by rigorous, up-to-date evidence rather than habit. I’m incredibly excited to dive deep into these literature updates with all of you in Grand Cayman.
Drop a comment below: Have you phased gabapentin out of your institutional ERAS protocols yet? See you all in 2027!

05/22/2026

Triple-agonist (GLP1++) retatrutide is not yet FDA-approved and is projected to be submitted for approval in late 2026, with commercial release expected between late 2026 and 2028.
"Among the heaviest patients in the trial, the results were on par with those seen with gastric bypass surgery, the only effective treatment for most with severe obesity.

The drug, retatrutide, appears to be the most powerful yet in a wave of injections and pills that have transformed the treatment of obesity — so much so that some participants in other research have said they stopped taking retatrutide because they felt they were losing too much weight."
Article (locked): https://www.nytimes.com/2026/05/21/science/retatrutide-weight-loss-drug.html
PDF: https://bit.ly/NYT-retatrutide